Daniel specialises in advising and representing national and international clients in the life sciences sector. His focus is, among others, on all areas of pharmaceutical law, medical device law, pharmaceutical-advertising law, unfair competition law, and trademark law.
For more than 10 years, he has been coordinating and supervising disputes concerning competition law and trademark law for his clients and has, besides his specific focus on litigation, also longstanding experience in advising clients on regulatory and compliance matters, particularly, in the aforementioned areas of law, which is advantageous for conducting transactions. In context with managing litigation and advising his clients, Daniel is characterised by a strong client focus and his ability to find appropriate and efficient solutions to legal problems.
|Since 2017||Salary Partner, Taylor Wessing|
|2012 – 2017||Associate, Hogan Lovells International LLP|
|2009 – 2012||Legal counsel, Centre for Protection against Unfair Competition (Wettbewerbszentrale)|
Possible ban on the mail-order of prescription-only (Rx) medicinal products in Germany, Dr. Daniel Tietjen, March 2018
by multiple authors